Literature DB >> 26013155

How Does the Level of Sacral Resection for Primary Malignant Bone Tumors Affect Physical and Mental Health, Pain, Mobility, Incontinence, and Sexual Function?

Rishabh Phukan1, Tyler Herzog2, Patrick J Boland3, John Healey3, Peter Rose4, Franklin H Sim5, Michael Yazsemski5, Kathryn Hess2, Polina Osler2, Thomas F DeLaney6, Yen-Lin Chen6, Francis Hornicek2, Joseph Schwab2.   

Abstract

BACKGROUND: En bloc resection for treatment of sacral tumors is the approach of choice for patients with resectable tumors who are well enough to undergo surgery, and studies describe patient survival, postoperative complications, and recurrence rates associated with this treatment. However, most of these studies do not provide patient-reported functional outcomes other than binary metrics for bowel and bladder function postresection. QUESTIONS/PURPOSES: The purpose of this study was to use validated patient-reported outcomes tools to compare quality of life based on level of sacral resection in terms of (1) physical and mental health; (2) pain; (3) mobility; and (4) incontinence and sexual function.
METHODS: Our analysis included 33 patients (19 men, 14 women) who had a mean age of 53 years (range, 22-72 years) with a quality-of-life survey administered at a mean postoperative followup of 41 months (range, 6-123 months). The majority of patient-reported quality-of-life outcome surveys for this study were taken from the National Institute of Health's Patient Reported Outcome Measurement Information System (PROMIS) system. To assess physical and mental health, the PROMIS Global Items Survey with physical and mental subscores, Anxiety, and Depression scores were used. Pain outcomes were assessed using PROMIS Pain Intensity and Pain Interference surveys. Patient-reported lower extremity function was assessed using the PROMIS Mobility Survey. Patient-reported quality of life for sexual function was assessed using the PROMIS Sex Interest and Orgasm survey, whereas incontinence was measured using the International Continence Society Voiding and Incontinence scores and the Modified Obstruction and Defecation Score. Surveys were collected prospectively during clinic visits in the postoperative period. Patients were grouped by the level of osteotomy as determined by review of postoperative MRI or CT and half levels were grouped with the more cephalad level. This resulted in the inclusion of total sacrectomy (N = 6), S1 (N = 8), S2 (N = 10), S3 (N = 5), and S4 (N = 4). One-way analysis of variance tests on means or ranks were used to conduct statistical analysis between levels.
RESULTS: Patients with more caudal resections had higher physical health (95% confidence interval [CI] total sacrectomy 36-42 versus S4 50-64, p < 0.001), less intense pain (95% CI total sacrectomy 47-60 versus S4 28-37, p < 0.001), less interference resulting from pain (95% CI total sacrectomy 58-69 versus S4 36-51, p = 0.004), higher mobility (95% CI total sacrectomy 24-46 versus S4 59-59, p = 0.002), and were more functionally able to achieve orgasm (95% CI S1 1-1 versus S4 2.2-5.3, p = 0.043). No difference was found for PROMIS Global Item Mental Health Subscore, Sex Interest, Sex Satisfaction, modified obstruction and defecation score, and International Continence Society Voiding and Incontinence although this could be the result of an inadequate sample size.
CONCLUSIONS: Our analysis on patient-reported quality of life based on the level of bony resection in patients who underwent resection for primary sacral tumor indicates that patients with higher resections have more pain and loss of physical function in comparison to patients with lower resections. Additionally, use of the PROMIS outcomes allows for comparisons to normative data. LEVEL OF EVIDENCE: Level III, therapeutic study.

Entities:  

Mesh:

Year:  2016        PMID: 26013155      PMCID: PMC4746195          DOI: 10.1007/s11999-015-4361-3

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  22 in total

1.  Effects of major resection of the sacrum. Clinical studies on urogenital and anorectal function and a biomechanical study on pelvic strength.

Authors:  B Gunterberg
Journal:  Acta Orthop Scand Suppl       Date:  1976

2.  Neurourologic evaluation after resection of the sacrum.

Authors:  B Gunterberg; L Norlén; B Stener; T Sundin
Journal:  Invest Urol       Date:  1975-11

3.  Anorectal function after major resections of the sacrum with bilateral or unilateral sacrifice of sacral nerves.

Authors:  B Gunterberg; J Kewenter; I Petersén; B Stener
Journal:  Br J Surg       Date:  1976-07       Impact factor: 6.939

4.  Pelvic bone complications following radiation therapy of gynecologic malignancies: clinical evaluation of radiation-induced pelvic insufficiency fractures.

Authors:  Hitoshi Ikushima; Kyousuke Osaki; Shunsuke Furutani; Kyou Yamashita; Yoshiomi Kishida; Takaharu Kudoh; Hiromu Nishitani
Journal:  Gynecol Oncol       Date:  2006-08-21       Impact factor: 5.482

5.  Anorectal and bladder function after sacrifice of the sacral nerves.

Authors:  S Nakai; H Yoshizawa; S Kobayashi; K Maeda; Y Okumura
Journal:  Spine (Phila Pa 1976)       Date:  2000-09-01       Impact factor: 3.468

6.  Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients.

Authors:  P Bergh; L G Kindblom; B Gunterberg; F Remotti; W Ryd; J M Meis-Kindblom
Journal:  Cancer       Date:  2000-05-01       Impact factor: 6.860

7.  Total sacrectomy and reconstruction: oncologic and functional outcome.

Authors:  P Wuisman; O Lieshout; S Sugihara; M van Dijk
Journal:  Clin Orthop Relat Res       Date:  2000-12       Impact factor: 4.176

8.  Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases.

Authors:  P Bergh; B Gunterberg; J M Meis-Kindblom; L G Kindblom
Journal:  Cancer       Date:  2001-04-01       Impact factor: 6.860

9.  Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients.

Authors:  Patrick C Hsieh; Risheng Xu; Daniel M Sciubba; Matthew J McGirt; Clarke Nelson; Timothy F Witham; Jean-Paul Wolinksy; Ziya L Gokaslan
Journal:  Spine (Phila Pa 1976)       Date:  2009-09-15       Impact factor: 3.468

10.  Maintenance of bowel, bladder, and motor functions after sacrectomy.

Authors:  Dane Moran; Patricia L Zadnik; Tessa Taylor; Mari L Groves; Alp Yurter; Jean-Paul Wolinsky; Timothy F Witham; Ali Bydon; Ziya L Gokaslan; Daniel M Sciubba
Journal:  Spine J       Date:  2014-09-06       Impact factor: 4.166

View more
  22 in total

1.  CORR(®) Tumor Board: Sacral Insufficiency Fractures are Common After High-dose Radiation for Sacral Chordomas Treated With or Without Surgery.

Authors:  Megan E Anderson; Jim S Wu; Sara O Vargas
Journal:  Clin Orthop Relat Res       Date:  2015-12-07       Impact factor: 4.176

Review 2.  Health-Related Quality of Life After Spine Surgery for Primary Bone Tumour.

Authors:  Raphaële Charest-Morin; Nicolas Dea; Charles G Fisher
Journal:  Curr Treat Options Oncol       Date:  2016-02

3.  Patient-Specific Three-Dimensional Model for a Safe Surgical Pathway in Sacral Chondrosarcoma.

Authors:  Anil Murat Ozturk; Mehmet Asim Ozer; Onur Suer; Okan Derin; Figen Govsa; Burcin Kececi; Dundar Sabah
Journal:  Indian J Surg Oncol       Date:  2018-12-08

4.  Low dose radiotherapy is associated with local complications but not disease control in sacral chordoma.

Authors:  Matthew T Houdek; Peter S Rose; Mario Hevesi; Joseph H Schwab; Anthony M Griffin; John H Healey; Ivy A Petersen; Thomas F DeLaney; Peter W Chung; Michael J Yaszemski; Jay S Wunder; Francis J Hornicek; Patrick J Boland; Franklin H Sim; Peter C Ferguson
Journal:  J Surg Oncol       Date:  2019-02-07       Impact factor: 3.454

5.  CORR Insights®: What are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients with Sacral Chordoma?

Authors:  Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2016-05-16       Impact factor: 4.176

6.  CORR Insights®: How Does the Level of Nerve Root Resection in En Bloc Sacrectomy Influence Patient-Reported Outcomes?

Authors:  Nicola Fabbri
Journal:  Clin Orthop Relat Res       Date:  2016-05-20       Impact factor: 4.176

Review 7.  Immunotherapy as a Potential Treatment for Chordoma: a Review.

Authors:  Shalin S Patel; Joseph H Schwab
Journal:  Curr Oncol Rep       Date:  2016-09       Impact factor: 5.075

8.  What questionnaires to use when measuring quality of life in sacral tumor patients: the updated sacral tumor survey.

Authors:  Olivier D R van Wulfften Palthe; Stein J Janssen; Jay S Wunder; Peter C Ferguson; Guo Wei; Peter S Rose; Micheal J Yaszemski; Franklin H Sim; Patrick J Boland; John H Healey; Francis J Hornicek; Joseph H Schwab
Journal:  Spine J       Date:  2016-11-14       Impact factor: 4.166

9.  CORR Insights®: Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?

Authors:  John H Healey
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

10.  How Does the Level of Nerve Root Resection in En Bloc Sacrectomy Influence Patient-Reported Outcomes?

Authors:  Olivier D R van Wulfften Palthe; Matthew T Houdek; Peter S Rose; Michael J Yaszemski; Franklin H Sim; Patrick J Boland; John H Healey; Francis J Hornicek; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.